Suscribirse

High Incidence of Autonomic Dysfunction and Postural Orthostatic Tachycardia Syndrome in Patients with Long COVID: Implications for Management and Health Care Planning - 10/02/25

Doi : 10.1016/j.amjmed.2023.06.010 
Marie-Claire Seeley, MNurs a, b, Celine Gallagher, PhD a, b, Eric Ong, BMedSci a, c, Amy Langdon, BHealthSci a, c, Jonathan Chieng, BHealthMedSci a, Danielle Bailey, BHealthMedSci a, Amanda Page, PhD d, Han S. Lim, MBBS, PhD e, Dennis H. Lau, MBBS, PhD a, b,
a Australian Dysautonomia and Arrhythmia Research Collaborative, Faculty of Health and Medical Sciences, The University of Adelaide, South Australia, Australia 
b South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia 
c College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia 
d Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia 
e Austin and Northern Health, The University of Melbourne, Victoria, Australia 

Requests for reprints should be addressed to Dennis H. Lau, MBBS, PhD, Department of Cardiology, Royal Adelaide Hospital, 1 Port Road, Adelaide, SA 5000, AUSTRALIA.Department of CardiologyRoyal Adelaide Hospital1 Port RoadAdelaideSA5000AUSTRALIA

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Autonomic dysfunction, including postural orthostatic tachycardia syndrome (POTS), has been reported in individuals with post-acute sequelae of COVID-19 (PASC). However, the degree of dysautonomia in PASC has not been compared to those with POTS and healthy controls.

Methods

All participants were prospectively enrolled between August 5, 2021 and October 31, 2022. Autonomic testing included beat-to-beat hemodynamic monitoring to assess respiratory sinus arrhythmia, Valsalva ratio, and orthostatic changes during a 10-minute active standing test, as well as sudomotor assessment. The Composite Autonomic Symptom Score (COMPASS-31) was used to assess symptoms and the EuroQuol 5-Dimension survey (EQ-5D-5L) was used to assess health-related quality of life (HrQoL) measures.

Results

A total of 99 participants (n = 33 PASC, n = 33 POTS, and n = 33 healthy controls; median age 32 years, 85.9% females) were included. Compared with healthy controls, the PASC and POTS cohorts demonstrated significantly reduced respiratory sinus arrhythmia (P < .001), greater heart rate increase during 10-minute active standing test (P < .001), greater burden of autonomic dysfunction evidenced by higher COMPASS-31 scores across all subdomains (all P < .001), and poor HrQoL across all EQ-5D-5L domains (all P < .001), lower median EuroQol-visual analogue scale (P < .001), and lower utility scores (P < .001). The majority (79%) of those with PASC met the internationally established criteria for POTS.

Conclusion

The prevalence of autonomic symptomology for POTS was high in those with PASC, leading to poor HrQoL and high health disutility. Autonomic testing should be routinely undertaken in those with PASC to aid diagnosis and direct appropriate management to improve health outcomes.

El texto completo de este artículo está disponible en PDF.

Graphical Abstract




 : 

High incidence of autonomic dysfunction with high symtom burden and significant impairment in health-related quality of life in those with PASC


High incidence of autonomic dysfunction with high symtom burden and significant impairment in health-related quality of life in those with PASCImage, graphical abstract

El texto completo de este artículo está disponible en PDF.

Keywords : Autonomic function, Dysautonomia, Long COVID, Orthostatic intolerance, Post-acute sequelae of COVID-19, Postural orthostatic tachycardia syndrome


Esquema


 Funding: This work was supported by a research grant from Standing up to POTS (North Hampton, Ohio, USA) and an equipment grant from The Australian POTS Foundation (Adelaide, SA, Australia).
 Conflicts of Interest: M-CS is supported by an Australian Government Research scholarship; DHL reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Abbott Medical, Biotronik, Medtronic, and MicroPort CRM. All other authors have no conflicts of interest to declare.
 Authorship: All authors contributed significantly to this work and had access to the data, with role in writing the manuscript.
 Trial registration: ANZCTR 12621000476831


© 2023  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 138 - N° 2

P. 354 - février 2025 Regresar al número
Artículo precedente Artículo precedente
  • Clinical and Laboratory Characteristics of Fatigue-Dominant Long-COVID Subjects: A Cross-Sectional Study
  • Jin-Seok Lee, Yujin Choi, Jin-Yong Joung, Chang-Gue Son
| Artículo siguiente Artículo siguiente
  • Unraveling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID
  • Patricia Palau, Beatriz Calvo, Clara Sastre, Eloy Domínguez, Paloma Marín, Cristina Flor, Julio Núñez, Laura López

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.